Dermatologist Censured for Plagiarism

A Case Western dermatologist has admitted to plagiarizing a grant she reviewed, plus taking text from eight research papers and a patent application.

Written byChris Palmer
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, FEATHEREDTARPratima Karnik, an assistant professor of dermatology at Case Western Reserve University, has been censured by the US Department of Health and Human Services’ Office of Research Integrity (ORI) for plagiarizing work from several sources in support of a recent grant proposal, according to a statement released Tuesday (August 6) in the Federal Register.

ORI officials found that significant portions of Karnik’s recent grant proposal to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) were lifted from a different NIAMS grant she had been asked to review. ORI also concluded that Karnik lifted text from eight research papers, including papers appearing in Nature and BMC Medical Genomics, as well as from a US patent application that was available online.

Karnik, who studies cicatricial alopecia—a rare disorder in which inflammation destroys hair follicles, causing permanent hair loss—has admitted to the misconduct and has agreed to have her research activities supervised for 2 years, beginning last month. During this time, she must submit a plan detailing how her participation in any projects funded by the US Public Health ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies